Federal Circuit· 5/24/2007

In Re Bayer Aktiengesellschaft

Citations

488 F.3d 960
82 U.S.P.Q. 2d (BNA) 1828
2007 U.S. App. LEXIS 12100
2007 WL 1502078

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

noting, in comparing ASPIRINA to aspirin, that “[a]dding an ‘a’ to aspirin results in virtually no distinction with respect to the visual impressions of the terms.”
deeming Google® search results that provided very little context of the use of ASPIRINA to be “of little value in assessing the consumer public perception of the ASPIRINA mark”
deeming Google® search results that provided very little context of the use of ASPIRINA to be “of little value in assessing the consumer public perception of the ASPIRINA mark”
deeming GOOGLE search results that provided very little context of the use of ASPIRINA to be “of little value in assessing the consumer public perception of the ASPIRINA mark”
deeming GOOGLE search results that provided very little context of the use of ASPIRINA to be “of little value in assessing the consumer public perception of the ASPIRINA mark”
deeming Google® search results that provided very little context of the use of ASPIRINA to be “of little value in assessing the consumer public perception of the ASPIRINA mark”

Source: CourtListener parenthetical corpus (CC0).

Judges: Newman, Schall, Moore

Read full opinion on CourtListener

Cited by

91 cases in this archive cite this case; the 20 most cited are listed.

Cites

17 cases in this archive are cited by this case.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.